You have free access to this content

Hepatology

Cover image for Vol. 58 Issue 1

July 2013

Volume 58, Issue 1

Pages 1–453

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts (pages 43–53)

      Alexa Schieck, Andreas Schulze, Caroline Gähler, Thomas Müller, Uwe Haberkorn, Alexander Alexandrov, Stephan Urban and Walter Mier

      Article first published online: 15 MAY 2013 | DOI: 10.1002/hep.26211

    4. You have free access to this content
    5. You have free access to this content
      Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution (pages 65–72)

      Umberto Arena, Monica Lupsor Platon, Cristina Stasi, Stefania Moscarella, Alì Assarat, Giorgio Bedogni, Valeria Piazzolla, Radu Badea, Giacomo Laffi, Fabio Marra, Alessandra Mangia and Massimo Pinzani

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26343

    6. You have free access to this content
    7. You have free access to this content
      The antimalarial ferroquine is an inhibitor of hepatitis C virus (pages 86–97)

      Thibaut Vausselin, Noémie Calland, Sandrine Belouzard, Véronique Descamps, Florian Douam, François Helle, Catherine François, Dimitri Lavillette, Gilles Duverlie, Ahmed Wahid, Lucie Fénéant, Laurence Cocquerel, Yann Guérardel, Czeslaw Wychowski, Christophe Biot and Jean Dubuisson

      Article first published online: 14 MAY 2013 | DOI: 10.1002/hep.26273

    8. You have free access to this content
      Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection (pages 98–107)

      Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi and Hiromitsu Kumada

      Article first published online: 6 MAR 2013 | DOI: 10.1002/hep.26180

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice (pages 108–119)

      Phillipp Hartmann, Peng Chen, Hui J. Wang, Lirui Wang, Declan F. McCole, Katharina Brandl, Peter Stärkel, Clara Belzer, Claus Hellerbrand, Hidekazu Tsukamoto, Samuel B. Ho and Bernd Schnabl

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26321

    2. You have free access to this content
      Intestinal microbiota in patients with nonalcoholic fatty liver disease (pages 120–127)

      Marialena Mouzaki, Elena M. Comelli, Bianca M. Arendt, Julia Bonengel, Scott K. Fung, Sandra E. Fischer, Ian D. McGilvray and Johane P. Allard

      Article first published online: 14 MAY 2013 | DOI: 10.1002/hep.26319

    3. You have free access to this content
      Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice (pages 128–138)

      Angelina Mouralidarane, Junpei Soeda, Clara Visconti-Pugmire, Anne-Maj Samuelsson, Joaquim Pombo, Xanthi Maragkoudaki, Adil Butt, Ruma Saraswati, Marco Novelli, Guiseppe Fusai, Lucilla Poston, Paul D. Taylor and Jude A. Oben

      Article first published online: 31 MAY 2013 | DOI: 10.1002/hep.26248

  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma (pages 139–149)

      Junliang Fu, Zheng Zhang, Lin Zhou, Zhaorui Qi, Shaojun Xing, Jiyun Lv, Jianfei Shi, Baoyun Fu, Zhenwen Liu, Ji-Yuan Zhang, Lei Jin, Yulai Zhao, George K.K. Lau, Jingmin Zhao and Fu-Sheng Wang

      Article first published online: 15 FEB 2013 | DOI: 10.1002/hep.26054

    2. You have free access to this content
    3. You have free access to this content
      MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway (pages 158–170)

      Xin Yang, Lei Liang, Xiao-Fei Zhang, Hu-Liang Jia, Yi Qin, Xu-Chao Zhu, Xiao-Mei Gao, Peng Qiao, Yan Zheng, Yuan-Yuan Sheng, Jin-Wang Wei, Hai-Jun Zhou, Ning Ren, Qing-Hai Ye, Qiong-Zhu Dong and Lun-Xiu Qin

      Article first published online: 5 JUN 2013 | DOI: 10.1002/hep.26305

    4. You have free access to this content
      Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma (pages 171–181)

      Xi-Dai Long, Jin-Guang Yao, Zhi Zeng, Yun Ma, Xiao-Ying Huang, Zhong-Hua Wei, Min Liu, Jian-Jun Zhang, Feng Xue, Bo Zhai and Qiang Xia

      Article first published online: 14 MAY 2013 | DOI: 10.1002/hep.26311

    5. You have free access to this content
      Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520 (pages 182–191)

      Yun-Yong Park, Sang-Bae Kim, Hee Dong Han, Bo Hwa Sohn, Ji Hoon Kim, Jiyong Liang, Yiling Lu, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Gordon B. Mills, Anil K. Sood and Ju-Seog Lee

      Article first published online: 15 MAY 2013 | DOI: 10.1002/hep.26310

    6. You have free access to this content
      Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis (pages 192–204)

      Tamara Potikha, Evgeniy Stoyanov, Orit Pappo, Antonina Frolov, Lina Mizrahi, Deborah Olam, Temima Shnitzer-Perlman, Ido Weiss, Neta Barashi, Amnon Peled, Gabriele Sass, Gisa Tiegs, Francoise Poirier, Gabriel A. Rabinovich, Eithan Galun and Daniel Goldenberg

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26335

    7. You have free access to this content
    8. You have free access to this content
      Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course (pages 218–228)

      Shunsuke Muramatsu, Shinji Tanaka, Kaoru Mogushi, Rama Adikrisna, Arihiro Aihara, Daisuke Ban, Takanori Ochiai, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Koh Nakayama, Hiroshi Tanaka, Shoji Yamaoka and Shigeki Arii

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26345

    9. You have free access to this content
      Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification (pages 229–238)

      Diren Beyoğlu, Sandrine Imbeaud, Olivier Maurhofer, Paulette Bioulac-Sage, Jessica Zucman-Rossi, Jean-François Dufour and Jeffrey R. Idle

      Article first published online: 8 MAY 2013 | DOI: 10.1002/hep.26350

    10. You have free access to this content
      Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma (pages 239–250)

      Yi-Wei Wang, Kuen-Tyng Lin, Shu-Chuan Chen, De-Leung Gu, Chian-Feng Chen, Pang-Hsien Tu and Yuh-Shan Jou

      Article first published online: 23 MAY 2013 | DOI: 10.1002/hep.26352

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      GABA induces the differentiation of small into large cholangiocytes by activation of Ca2+/CaMK I-dependent adenylyl cyclase 8 (pages 251–263)

      Romina Mancinelli, Antonio Franchitto, Shannon Glaser, Fanyin Meng, Paolo Onori, Sharon DeMorrow, Heather Francis, Julie Venter, Guido Carpino, Kimberley Baker, Yuyan Han, Yoshiyuki Ueno, Eugenio Gaudio and Gianfranco Alpini

      Article first published online: 14 MAY 2013 | DOI: 10.1002/hep.26308

    2. You have free access to this content
      Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study (pages 264–272)

      Li-Na Zhang, Tian-Yan Shi, Xu-Hua Shi, Li Wang, Yun-Jiao Yang, Bin Liu, Li-Xia Gao, Zong-Wen Shuai, Fang Kong, Hua Chen, Wei Han, Shao-Mei Han, Yun-Yun Fei, Quan-Cai Cui, Qian Wang, Min Shen, Dong Xu, Wen-Jie Zheng, Yong-Zhe Li, Wen Zhang, Xuan Zhang and Feng-Chun Zhang

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26322

    3. You have free access to this content
      Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study (pages 273–283)

      George F. Mells, Greta Pells, Julia L. Newton, Andrew J. Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James M. Neuberger, Darren B. Day, Samantha J. Ducker, Richard N. Sandford, Graeme J. Alexander, David E.J. Jones and UK-PBC Consortium

      Article first published online: 24 JUN 2013 | DOI: 10.1002/hep.26365

    4. You have free access to this content
    5. You have free access to this content
  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure (pages 304–313)

      R. Todd Stravitz, Regina Bowling, Robert L. Bradford, Nigel S. Key, Sam Glover, Leroy R. Thacker and Don A. Gabriel

      Article first published online: 14 MAY 2013 | DOI: 10.1002/hep.26307

    2. You have free access to this content
      Alcohol dehydrogenase–specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis (pages 314–324)

      Fang Lin, Nicholas J. Taylor, Haibin Su, Xiaohong Huang, Munther J. Hussain, Robin Daniel Abeles, Laura Blackmore, Yunyun Zhou, Mohammad Mashfick Ikbal, Nigel Heaton, Wayel Jassem, Debbie L. Shawcross, Diego Vergani and Yun Ma

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26334

    3. You have free access to this content
      The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus (pages 325–336)

      Piero Amodio, Chantal Bemeur, Roger Butterworth, Juan Cordoba, Akinobu Kato, Sara Montagnese, Misael Uribe, Hendrik Vilstrup and Marsha Y. Morgan

      Article first published online: 31 MAY 2013 | DOI: 10.1002/hep.26370

    4. You have free access to this content
      C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice (pages 337–350)

      Po-sung Chu, Nobuhiro Nakamoto, Hirotoshi Ebinuma, Shingo Usui, Keita Saeki, Atsuhiro Matsumoto, Yohei Mikami, Kazuo Sugiyama, Kengo Tomita, Takanori Kanai, Hidetsugu Saito and Toshifumi Hibi

      Article first published online: 31 MAY 2013 | DOI: 10.1002/hep.26351

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury (pages 351–362)

      Naoko Kamo, Bibo Ke, Amir A. Ghaffari, Xiu-da Shen, Ronald W. Busuttil, Genhong Cheng and Jerzy W. Kupiec-Weglinski

      Article first published online: 15 MAY 2013 | DOI: 10.1002/hep.26320

    2. You have free access to this content
      Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice (pages 363–373)

      Tobias Pusterla, Julia Nèmeth, Ilan Stein, Lars Wiechert, David Knigin, Silke Marhenke, Thomas Longerich, Varun Kumar, Bernd Arnold, Arndt Vogel, Angelika Bierhaus, Eli Pikarsky, Jochen Hess and Peter Angel

      Article first published online: 24 JUN 2013 | DOI: 10.1002/hep.26395

    3. You have free access to this content
      Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice (pages 374–387)

      Gary W. Nace, Hai Huang, John R. Klune, Raymond E. Eid, Brian R. Rosborough, Sebastian Korff, Shen Li, Richard A. Shapiro, Donna B. Stolz, Chhinder P. Sodhi, David J. Hackam, David A. Geller, Timothy R. Billiar and Allan Tsung

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26346

    4. You have free access to this content
  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents (pages 397–408)

      Ina Rittelmeyer, Michael Rothe, Martijn H. Brugman, Marcus Iken, Axel Schambach, Michael P. Manns, Christopher Baum, Ute Modlich and Michael Ott

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26204

    2. You have free access to this content
      Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases (pages 409–421)

      Tatyana V. Masyuk, Brynn N. Radtke, Angela J. Stroope, Jesús M. Banales, Sergio A. Gradilone, Bing Huang, Anatoliy I. Masyuk, Marie C. Hogan, Vicente E. Torres and Nicholas F. LaRusso

      Article first published online: 6 MAR 2013 | DOI: 10.1002/hep.26140

  9. Public Policy Corner

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
  10. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
  11. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Interferon-lambda polymorphisms and hepatitis C virus clearance revisited (pages 439–441)

      Joachim Lupberger, Daniel J. Felmlee and Thomas F. Baumert

      Article first published online: 17 MAY 2013 | DOI: 10.1002/hep.26443

    2. You have free access to this content
  12. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      Now you see it, now you don't (pages 446–447)

      Eileen Plotkin, David N. Assis and James L. Boyer

      Article first published online: 24 JUN 2013 | DOI: 10.1002/hep.26439

  13. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Public Policy Corner
    11. Reviews
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    1. You have free access to this content
      B-cell frequency in hepatitis C virus-related mixed cryoglobulinemia (page 448)

      Domenico Sansonno, Sabino Russi, Vincenza Conteduca and Loredana Sansonno

      Article first published online: 27 MAY 2013 | DOI: 10.1002/hep.26117

    2. You have free access to this content
      Reply: B-cell frequency in HCV-related mixed cryoglobulinemia (pages 448–449)

      Lauren E. Holz, Joo Chun Yoon, Sukanya Raghuraman, Susan Moir, Michael C. Sneller and Barbara Rehermann

      Article first published online: 29 MAY 2013 | DOI: 10.1002/hep.26112

    3. You have free access to this content
      3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease (pages 449–450)

      Lavrentios Papalavrentios, Emmanouil Sinakos, Danai Chourmouzi, Prodromos Hytiroglou, Konstantinos Drevelegas, Antonios Drevelegas and Evangelos Akriviadis

      Article first published online: 24 JUN 2013 | DOI: 10.1002/hep.26220

    4. You have free access to this content
      Bayesian prediction for liver fibrosis staging: Combined use of elastography and serum fibrosis markers (pages 450–451)

      Utaroh Motosugi, Tomoaki Ichikawa, Tsutomu Araki, Masanori Matsuda, Hideki Fujii and Nobuyuki Enomoto

      Article first published online: 26 APR 2013 | DOI: 10.1002/hep.26144

    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      Reply: (pages 452–453)

      Sasan Roayaie, Josep Llovet, Myron Schwartz and Vincenzo Mazzaferro

      Article first published online: 28 MAY 2013 | DOI: 10.1002/hep.26241

SEARCH

SEARCH BY CITATION